FDA Adverse Event Injury Summary report: N

ASR ACETABULAR CUPS 52

MDR report key: 4121035 · Received September 26, 2014

Report

Report Number
1818910-2014-28869
Event Type
Injury
Date Received
September 26, 2014
Date of Event
April 2, 2014
Report Date
October 27, 2014
Manufacturer
DEPUY INTL., LTD. - 8010379
Product Code
KWA
PMA / PMN Number
PK040627
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. REF. WWCAPA (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED. (B)(6).

Additional Manufacturer Narrative · 1

ADDITIONAL NARRATIVE: IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. DEPUY STILL CONSIDERS THIS INVESTIGATION CLOSED.

Description of Event or Problem · 1

UPDATE REC¿D 10/27/2014 - PLAINTIFF¿S PRELIMINARY DISCLOSURE FORM WAS RECEIVED, WHICH IDENTIFIED DOB INFORMATION. THE STEM AND SLEEVE ARE BEING ADDED TO THE COMPLAINT. THE COMPLAINT AND ASSOCIATED MDRS WERE UPDATED. THERE WAS NO NEW INFORMATION THAT WOULD CHANGE THE OUTCOME OF THE INVESTIGATION. THE COMPLAINT WAS UPDATED ON: 11/25/2014.

Description of Event or Problem · 1

LITIGATION PAPERS ALLEGE PAIN AND EXCESSIVE METAL ION LEVELS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
601539 ASR ACETABULAR CUPS 52 HIP ACETABULAR CUP KWA DEPUY INTL., LTD. - 8010379 2835708

Patients

Seq Age Sex Outcome Treatment
1 71 YR Required Intervention